glp-1/gip/glucagon triple agonist name Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor Triple Agonism Based Therapies for

S5A and S5B), the reasons for -cell functional failure in LOsG group could be hardly explained by the limited extra loss of -cells on LOsG treatment day P38

10.1172/JCI24134 151 TomitaM.MizunoS.YamanakaH.HosodaY.SakumaK.MatuokaY.et al (2000)

Observed aging effects and their comparison to the literature

10.1095/biolreprod58.1.261 Biol

Increasingly used to support weight loss (with several countries authorizing the prescription of Novo Nordisks Wegovy and Eli Lillys Zepbound/Mounjaro drugs for weight management), the companies behind these drugs are reporting rapid sales growth and have seen their share prices rise significantly